Although ATO also activated JNK in CLL cells, inhibition of this kinase did not decrease MMP-9 induction, ruling out its role in the upregulation of MMP-9 in these conditions. The gene discussed is MMP9; the disease is B-cell chronic lymphocytic leukemia.